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Abstract
The widespread use of antimicrobial agents, in combination with insufﬁcient infection control measures, is the main driver of the cur-
rent pandemic of antimicrobial resistance in human pathogens. The use of antimicrobials in food animal production also contributes,
because resistant organisms and resistance genes can spread from animals to humans by direct contact or through the food chain. An
important, traditionally human, pathogen, methicillin-resistant Staphylococcus aureus (MRSA), is currently endemic in many hospitals
around the world and has also emerged in the community. Recently, a new reservoir of MRSA has been identiﬁed in food production
animals and people in contact with these animals. This involves a speciﬁc clone, multilocus sequence type 398 (ST398), which has spread
extensively among animals. ST398 has also been found in up to 11.9% of retail meat samples in several surveys from different parts of
the world, posing a potential threat to human health.
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Introduction
Antimicrobial agents are widely used not only in human and
veterinary medicine, but also in animal husbandry and other
agricultural activities. This has contributed to an alarming
increase in antimicrobial resistance [1,2]. Transmission of
resistant bacteria from farm animals to humans can occur
not only by contact with the animals but also through con-
tact with, or ingestion of, food products of animal origin
[3,4]. Depending on the virulence of the microorganism
involved, this can lead to human disease that is more difﬁcult
to treat because of the presence of antimicrobial resistance.
Additionally, ingested resistant bacteria can transfer their
resistance genes to bacteria of the human commensal ﬂora
[5,6]. The objective of this review is to describe the epidemi-
ology of methicillin-resistant Staphylococcus aureus (MRSA) in
humans and animals, its occurrence in food products, and its
consequences for human health.
Colonization and Infection with S. aureus
S. aureus is a Gram-positive, coagulase-positive coccus of the
family Staphylococcaceae. Staphylococcal species occur world-
wide as commensal colonizers of the skin of animals and
humans. They are additionally found on mucous membranes
of the upper respiratory tract and lower urogenital tract, and
transiently in the digestive tract. Staphylococci are resistant to
dehydration and are stable for months in the environment [7].
Colonization with S. aureus may occur on mucous membranes
of the respiratory and/or intestinal tract, or on other body
surfaces, and this is usually asymptomatic [3,8]. The prevalence
of nasal colonization with S. aureus among the human popula-
tion is relatively high (c. 30%), whereas the prevalence of nasal
colonization with MRSA among the same group is low; the
highest rate reported in a population-based survey was 1.5%
[9,10]. Some individuals are colonized transiently and some
persistently [11]. In healthy people, carriage is associated with
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a minor risk of developing an infection. However, when the
integrity of the skin is broken, the risk of infection increases
dramatically. One of the ﬁrst reports clearly demonstrating
this relationship, in 1952, was performed among miners who
suffered from beat disorders (bruises and skin lesions) of the
knees and elbows [12].
The situation in miners can be compared to that of patients
in hospitals, whose breaks in skin integrity also provide an
entry for S. aureus. This is especially true for surgical patients,
but non-surgical patients are also at risk, owing to the use of
invasive devices (e.g. patients on dialysis, patients with human
immunodeﬁciency virus, patients with organ transplants,
patients with Wegener’s granulomatosis, patients in the inten-
sive-care unit, or patients with intravascular catheters) [13].
MRSA: Underlying Mechanisms,
Epidemiology and Clinical Relevance
The methicillin resistance of S. aureus is conferred by the
mecA gene, which codes for a variant of penicillin-binding
protein (PBP), PBP2a. PBPs, which are normally present at
the cell membrane of S. aureus, are bound by penicillin and,
consequently, cell membrane synthesis is discontinued,
resulting in bacterial death. However, PBP2a has a reduced
afﬁnity for b-lactam antibiotics, leaving the cell membrane
intact and the organism alive [14]. The mecA gene resides on
a mobile genetic element, the staphylococcal cassette
chromosome mec (SCCmec) [15]. SCCmec contains a mec
complex, which includes the mecA gene and one or two
regulatory genes, and a cassette chromosome recombinase
(ccr) gene complex, which regulates the insertion and exci-
sion of the cassette into the bacterial chromosome. So far,
eight different mec complexes and four different ccr genes
have been described [15–17].
MRSA was ﬁrst reported in 1961, shortly after methicillin
became available. However, it took several decades before it
became a clinical problem. For example, in the USA and the
UK, the proportion of S. aureus strains causing bacteraemia
that were methicillin-resistant started to increase around
1990; by the start of the 21st century, approximately half of
the strains causing bacteraemia were resistant [18]. At pres-
ent, hospital-acquired MRSA is globally endemic, except in
Scandinavian countries and The Netherlands, where it is con-
trolled by extensive measures called ‘search and destroy’.
Recently, new strains of S. aureus with diverse genetic
backgrounds have acquired the methicillin resistance cas-
sette, because of the emergence of smaller and more easily
acquired cassettes (types IV and V) [19]. These community-
acquired strains of MRSA successfully compete with suscepti-
ble strains outside of the hospital, and can cause epidemics
in closed communities and healthcare institutions.
Observational cohort studies have consistently found that
MRSA infection is associated with excess healthcare costs
and prolonged hospital stay for surgical and critically ill
patients, after adjusting for comorbidities and hospital events
before infection [20]. In addition, in two cohort studies from
Canada and the UK, MRSA did not replace methicillin-
susceptible S. aureus, but accounted for increasing rates of
S. aureus bacteraemia [21,22]. A survey of all US hospitals
estimated the occurrence and effects of S. aureus infections
over time [23]. Infections increased from 258 000 in 1998 to
480 000 in 2005. In 2003, the associated incremental costs
of staphylococcal disease were c. $14.5 billion. Another
study estimated the occurrence of invasive MRSA infections
in the USA in 2005 to be 100 000, and the number of asso-
ciated deaths to be 19 000 [24].
MRSA in Animals
The isolation of MRSA from animals was ﬁrst reported in
1972, following its detection in milk from mastitic cows [25].
Since then, MRSA has been isolated from many different ani-
mal species, including dogs, cats, horses, sheep, pigs, dairy
cows, veal calves and fowl. This was recently reviewed by
Leonard and Markey, who suggested that MRSA may be an
emerging pathogen in companion animals and horses [26].
However, a distinction should be made between food pro-
duction animals and individually housed animals, which are,
predominantly, kept for companionship and leisure activities.
When it is found in companion animals, the presence of
MRSA is mainly due to transmission from a human reservoir
[27–29]. In food production animals, a new strain of MRSA
(ST398; see below) emerged recently [11,30,31], and people
working with living pigs or veal calves were found to be col-
onized from these animal reservoirs. A French group that
studied the occurrence of S. aureus in pigs and pig farmers at
the turn of the century ﬁrst mentioned this animal reservoir
[32]. They found that pig farmers were more frequently col-
onized with S. aureus, including MRSA, than non-farmers. In
addition, the strains from non-farmers and farmers were dif-
ferent, whereas strains from pig farmers were identical to
the strains in pigs. One of the types that was found only in
pig farmers was multilocus sequence type 398 (ST398). A
few years later, Voss et al. [33] reported ST398 in pig farm-
ers and pigs in The Netherlands. This prompted additional
investigations into the epidemiology of MRSA in pigs, show-
ing that ST398 had spread extensively. Dutch studies have
reported prevalences at the farm level varying from 23% to
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81% [34,35] (Broens et al., Proceedings of the 1st American
Society of Microbiology Conference on Antimicrobial Resis-
tance in Zoonotic Bacteria and Foodborne Pathogens, 2008,
Abstract A19). Later studies from Belgium (Dewaele et al.,
Proceedings of the 1st American Society of Microbiology
Conference on Antimicrobial Resistance in Zoonotic Bacteria
and Foodborne Pathogens 2008, Abstract A36), Denmark
[36], Germany [37], France [32], the USA (Smith et al., Inter-
national Conference on Emerging Infectious Diseases, 2008,
Abstract A17) and Canada [38] also reported the occur-
rence of this strain in pigs and pig farmers. A case–control
study conﬁrmed that humans colonized with ST398 had a
strong relationship with pig farms, deﬁning MRSA as a zoo-
notic pathogen [39]. In addition, this study showed a strong
relationship with exposure to veal calves. Subsequent studies
of veal farms revealed high prevalences of ST398 as well;
88% of the farms and 28% of the calves tested positive
(Graveland et al., Proceedings of the 1st American Society of
Microbiology Conference on Antimicrobial Resistance in
Zoonotic Bacteria and Foodborne Pathogens, 2008, Abstract
B84). Finally, ST398 has also been linked to poultry, but its
relationship to human carriage must be conﬁrmed in larger
surveys [30,31,40].
Several observations have conﬁrmed the potential of
ST398 to spread and cause disease among humans. However,
both the transmissibility and the virulence of ST398 are likely
to be less than those of other MRSA types, according to
two observational studies [41,42]. Therefore, the impact of
ST398 on public health may be limited, but close monitoring
of its evolution over time will be required.
MRSA in Food: Presence and Consequences
Contamination of food products with S. aureus is an impor-
tant cause of food poisoning. This is a form of gastroenteritis
that is manifested clinically as emesis, with or without diar-
rhoea. It results from ingestion of one or more preformed
staphylococcal enterotoxins on food that has been contami-
nated with S. aureus. Signs of systemic toxicity, such as fever
and hypotension, are rarely observed in cases of staphylo-
coccal food poisoning. It is a self-limiting condition that typi-
cally resolves within 24–48 h of onset. The exact incidence
is unknown, but it is probably the most common cause of
food poisoning in the USA.
Risk assessment in foodstuffs relies on classic microbial
detection and quantiﬁcation of coagulase-positive staphylo-
cocci on a selective Baird–Parker medium. For the develop-
ment of disease after consumption, the presence of bacterial
toxins cells above a certain threshold, as well as the produc-
tion of, is required. Therefore, in many countries, low-degree
contamination by S. aureus is tolerated in most foodstuffs (e.g.
up to 103 CFUs/g in raw milk cheeses in France), as this is not
considered to be a risk for public health [43]. Indeed, S. aureus
is found frequently in retail meat. Studies in Switzerland and
Japan showed prevalences of S. aureus in meat products of
23% and 65%, respectively [44,45]. The Swiss survey traced
the contamination of meat products back to certain abattoirs.
The emergence of ST398 has prompted surveys for the
presence of MRSA in meat. During slaughtering of MRSA-car-
rying animals, contamination of carcasses with MRSA may
occur, and consequently the meat of these animals may
become contaminated. A contemporary review of the pres-
ence of MRSA in food was recently released by the European
Food Safety Authority (http://www.efsa.europa.eu:80/cs/
BlobServer/Scientiﬁc_Opinion/biohaz_op_993_mrsa_en,3.pdf?
ssbinary=true). The most important and well-designed surveys
are described here. The Dutch Food Safety Agency sampled
various kinds of meat collected from the retail trade. MRSA
was isolated from 264 (11.9%) of 2217 samples analysed. Isola-
tion percentages for the meat species were as follows: beef,
10.6%; veal, 15.2%; lamb and mutton, 6.2%; pork, 10.7%;
chicken, 16.0%; turkey, 35.3%; fowl, 3.4%; and game, 2.2%. The
majority (85%) of the isolated strains belonged to ST398; the
other STs were possibly of human origin [46]. Another Dutch
survey found that 36 of 79 (46%) retail meat samples contained
S. aureus strains, of which two (2%) were methicillin-resistant:
one was ST398 and the other was USA300 [47]. This study
used molecular typing, and demonstrated that there was a high
degree of clonal relationship among S. aureus strains from
samples that came from a single retail shop, indicating cross-
transmission at some point during processing in the shop.
Therefore, the strain in the sample may not always be indica-
tive of the strain that was carried by the animal at source. In a
US survey, among 120 retail meat samples, 47 (39.2%) con-
tained S. aureus strains, six (5%) of which were MRSA. The
types found were USA100 (ST5) and USA300 (ST8) [48]. A
Canadian survey found that 31 of 402 (7.7%) retail meat sam-
ples harboured MRSA (Weese et al., 19th European Confer-
ence on Clinical Microbiology and Infectious Diseases, 2009,
Abstract O94). Three major types were obtained: ST398
(30%), ST8 (40%) and ST5 (30%). ST8 has also been found fre-
quently in horses, which may represent a source of contamina-
tion of meat. ST5 is a strain commonly found in humans in
both the USA and Canada.
It is clear from the aforementioned surveys that MRSA is
currently present in food, posing a potential risk for human
health. As mentioned, the main risk arising from the
presence of S. aureus in food is the development of food
poisoning. However, methicillin resistance is not a relevant
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factor for the production of enterotoxins, and food poison-
ing is not a disease that is treated with antibiotics. There-
fore, MRSA should not pose a greater risk of food poisoning
than methicillin-susceptible S. aureus. In fact, ST398 rarely
possesses toxin genes [49].
The second risk is the development of invasive disease fol-
lowing the ingestion of contaminated food; this is a rare event,
and has only been reported once in the literature, in the con-
text of a large hospital outbreak of MRSA, due to contamina-
tion of food products, in a hospital ward in Erasmus Medical
Centre in Rotterdam, The Netherlands [50]. In this outbreak,
a patient was probably infected following ingestion of MRSA-
contaminated food, and severe sepsis developed subsequently,
leading to death. The patient was severely immunocompro-
mised and received both antacids and antibiotics, to which the
outbreak strain was resistant. Therefore, under these extreme
conditions, it may be possible to develop invasive infection
after ingestion of S. aureus-contaminated food, but this is unli-
kely to be a risk for the majority of individuals.
The third potential risk is the possibility of becoming col-
onized with MRSA during food processing or consumption.
When meat is cooked properly, the potential risk related
to consumption is probably not relevant. Handling the meat
before cooking, however, does involve a risk of becoming
colonized. The risk largely depends on the hygienic mea-
sures taken, the amount of MRSA present, and the ability
of the strain itself to colonize the host. In this regard, it
should be noted that, in the studies on retail meat
mentioned above, the amount of S. aureus present in meat
samples was very low.
Conclusions and Recommendations
Over the past decades, the epidemiology of MRSA has
changed signiﬁcantly. Traditionally considered a nosocomial
pathogen, MRSA has recently also entered the community,
causing serious infections. Additionally, MRSA infection and
colonization have been documented in several animal species.
At the turn of the century, MRSA ST398, a novel clone
linked to food production animals, has also emerged in
humans. Molecular typing methods support the relationship
between this particular strain in food production animals and
humans who have been in contact with these animals. From
the animal reservoir, MRSA can be introduced into hospitals,
and serious infections and outbreaks can occur, as has been
reported incidentally so far. How critical this new develop-
ment is for human health, and the possibilities for appropriate
infection control, are currently being studied. Considering
the signiﬁcant spread among production animals, it is unlikely
that this reservoir will be eradicated easily. At present,
MRSA is also found commonly in retail meat, with a potential
for widespread dissemination in the population. On the
other hand, there are indications that ST398 does not spread
easily among humans and that its virulence is less than that
of other MRSA clones [41].
However, this assumption needs to be conﬁrmed in well-
designed studies before control measures are modiﬁed. Con-
sidering the potential implications of the reservoir in food
production animals and the widespread presence in meat,
the epidemiology of ST398 in humans needs to be monitored
carefully.
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